-+ 0.00%
-+ 0.00%
-+ 0.00%

AbbVie Lowers FY2026 Adj EPS Guidance from $14.08-$14.28 to $13.87-$14.07 vs $14.08 Est

Benzinga·07/31/2026 11:52:39
Listen to the news
AbbVie (NYSE:ABBV) lowers FY2026 Adj EPS guidance from $14.08-$14.28 to $13.87-$14.07 vs $14.08 analyst estimate..